Bromocriptine mesylate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0574-0106
  • Package NDC 0574-0106-01
  • Package NDC 0574-0106-03
  • Application number ANDA077646
  • SPL ID 3a655bc4-d44e-4dd2-a951-211d8484f788
  • SPL set ID 0ee2da00-faf8-4c51-a696-9462fa4f6050
  • UNII FFP983J3OD
  • RxCUI 197411

What the source publishes

Labeler
Padagis US LLC
Active ingredients
Bromocriptine mesylate
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788
{
  "name": "Bromocriptine mesylate",
  "splId": "3a655bc4-d44e-4dd2-a951-211d8484f788",
  "labels": [
    {
      "setId": "0ee2da00-faf8-4c51-a696-9462fa4f6050",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ee2da00-faf8-4c51-a696-9462fa4f6050",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ee2da00-faf8-4c51-a696-9462fa4f6050"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Padagis US LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01)",
      "package_ndc": "0574-0106-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140401"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03)",
      "package_ndc": "0574-0106-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140401"
    }
  ],
  "productId": "0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "0574-0106",
  "deaSchedule": null,
  "genericName": "Bromocriptine mesylate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BROMOCRIPTINE MESYLATE",
      "strength": "2.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA077646",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20140401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "FFP983J3OD"
    ],
    "rxcui": [
      "197411"
    ],
    "spl_set_id": [
      "0ee2da00-faf8-4c51-a696-9462fa4f6050"
    ],
    "manufacturer_name": [
      "Padagis US LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788"